Dose optimization of intrathecal administration of human umbilical cord mesenchymal stem cells for the treatment of subacute incomplete spinal cord injury

Human umbilical cord mesenchymal stem cells (hUC-MSCs) are a promising candidate for spinal cord injury (SCI) repair owing to their advantages of low immunogenicity and easy accessibility over other MSC sources. However, modest clinical efficacy hampered the progression of these cells to clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Ting-Ting, Chen, Huan, Pang, Mao, Xu, Si-Si, Wen, Hui-Quan, Liu, Bin, Rong, Li-Min, Li, Mang-Mang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820722/
https://www.ncbi.nlm.nih.gov/pubmed/35017439
http://dx.doi.org/10.4103/1673-5374.332151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820722/
https://www.ncbi.nlm.nih.gov/pubmed/35017439
http://dx.doi.org/10.4103/1673-5374.332151

Ejemplares similares